Medical Ozone for COVID19


yan
scaglio
jrgo

franzini

America’s Frontline Doctors SCOTUS Press Conference Transcript

White Paper on Hydroxychloroquine

AAA ebook Medical Studies Support MDs Prescribing Hydroxychloroquine for Early Stage COVID


Alberto-Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia

Alberto-Ozone Therapy for Patients with SARS-COV-2 pneumonia

Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19.Preliminary evidence reported

A novel functional beverage for COVID-19 and other   conditions: Hypothesis and preliminary data, increased blood flow, and wound healing.


Brownstein-Rowen Protocol

Ozone as adjuvant support in the treatment of COVID‐19:
A preliminary report of probiozovid trial

Complementary application of the  of the ozonized  saline solution in mild and severe patients with pneumonia COVID -19 : A non -randomized  pilot study.

James Perloff asks hard questions about the global response to COVID-19.


Ozone and pulsed electro-magnetic field therapies
improve endometrial lining thickness in frozen embryo transfer cycles - Three case reports.

SARS-CoV-2 viability on different surfaces after gaseous
ozone treatment: a preliminary evaluation.

Ozone Disinfection of SARS-Contaiminated Areas

Amelioration Of Symptoms And Oxidative Stress In Hospitalized Convalescent Post Sars-Cov-2 Patients.


Complementary application of the ozonized saline solution in mild and severe patients with pneumonia COVID-19: A non-randomized pilot study.

COVID-19 - How can I cure thee? Let me count the ways

Potential Cytoprotective Activity of Ozone Therapy in
SARS-CoV-2/COVID-19



More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by AAPS

This week the Association of American Physicians & Surgeons submitted additional evidence to a federal court for why interference with hydroxychloroquine (HCQ) should end by the Food & Drug Administration (FDA) and the Department of Health & Human Services (HHS), in AAPS v. FDA, No. 1:20-cv-00493-RJJ-SJB (W.D. Mich.).

“As confirmed by another recent study of thousands of patients at the Henry Ford Health System in Michigan, HCQ is both very safe and highly effective in treating COVID-19, reducing mortality by 50%,” AAPS informed the court in its filing. “Countries with underdeveloped health care systems are using HCQ early and attaining far lower mortality than in the United States, where [HHS and the FDA] impede access to HCQ.”

Yet most Americans are still unable to obtain HCQ for early treatment of COVID-19, and virtually no Americans are able to access it as preventive medicine. HCQ has been used safely for decades by travelers to protect against malaria, but Americans are dying from COVID-19 while HCQ is withheld from them.

“Citizens of the Philippines, Poland, Israel, and Turkey all have greater access to HCQ than American citizens do,” observes AAPS General Counsel Andrew Schlafly. “In Venezuela, HCQ is available over the counter without a prescription, while in the United States pharmacists are prevented from filling prescriptions for HCQ.”

AAPS rebuts arguments presented by the FDA, which implied that medications are approved as safe only for certain conditions. In fact, HCQ and most medications have been approved without limitation, such that physicians can prescribe them for any off-label use.

“The mortality rate from COVID-19 in countries that allow access to HCQ is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States,” explains Andrew Schlafly.

Polish chemists have even showed the world how to synthesize HCQ from cheaply, widely available ingredients. The cost of this medication is less than a dollar a dose, in contrast with the very expensive alternatives being pushed by FDA officials.

In its filing, the FDA insisted that the public has no right to access nearly 100 million doses of HCQ which were donated to the Strategic National Stockpile. HHS is having that medication waste away while Americans are dying from COVID-19.

“In some areas of Central America, officials are even going door to door to distribute HCQ,” Andrew Schlafly adds. “These countries have been successful in limiting the mortality from COVID-19 to only a fraction of what it is in wealthier countries.”

AAPS filed this lawsuit to obtain legal redress in support of Trump, by ending the obstruction by the FDA of his policies that would save lives.AAPS has represented physicians of all specialties in all states since 1943. The AAPS motto is omnia pro aegroto, meaning everything for the patient.



Screen-Shot-2020-03-25-at-2.51.05-PM-1280×728

Peer Reviewed Articles on Medical Ozone

error: Content is protected !!